Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 133Precursor Cell Lymphoblastic Leukemia-Lymphoma 115Myelodysplastic Syndromes 111Leukemia, Lymphocytic, Chronic, B-Cell 101Lymphoma, Non-Hodgkin 97Hodgkin Disease 94Leukemia 85Multiple Myeloma 84Lymphoma 71Lymphoma, Mantle-Cell 66Lymphoma, Follicular 66Lymphoma, Large B-Cell, Diffuse 63Leukemia, Myelogenous, Chronic, BCR-ABL Positive 60Myeloproliferative Disorders 58Lymphoma, B-Cell, Marginal Zone 57Burkitt Lymphoma 52Leukemia, Myelomonocytic, Chronic 51Congenital Abnormalities 50Leukemia, Myeloid, Chronic-Phase 49Lymphoma, Large-Cell, Immunoblastic 45Leukemia, Myeloid, Accelerated Phase 42Hematologic Neoplasms 42Anemia, Refractory, with Excess of Blasts 40Graft vs Host Disease 39Primary Myelofibrosis 36Waldenstrom Macroglobulinemia 33Neoplasms, Plasma Cell 32Blast Crisis 32Lymphoma, T-Cell, Cutaneous 30Recurrence 29

Interventions

thymoglobulin 1Prone Position 1Mycophenolic Acid 1Cyclosporine 1Antilymphocyte Serum 1Acetazolamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Neural Tube Defects × Mycophenolic Acid × Clear all
NCT01392989 2019-05-07

Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders

Stanford University

Phase 2 Completed
44 enrolled 13 charts
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Leukemia, Myeloid, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neural Tube Defects

Data powered by HemOnc (CC BY 4.0) Colophon âš¡